Redwood Trust, Inc. has cut its dividend by 90% and is converting from a Real Estate Investment Trust (REIT) to a taxable C-Corp structure. This move unlocks $304 million in federal net operating losses and increases the company's GAAP book value by $0.75 per share. Despite these changes, the company faces risks from its legacy portfolio, which includes $682 million in non-core assets and a high leverage ratio of 9:1. The shift aims to improve financial flexibility and value for shareholders amid challenging market conditions.
Redwood Trust's recent dividend cut and structural changes provide context for readers following real estate stocks. For readers following the real estate sector, here is Pluang's market snapshot as of Nov 05, 2026 00:11 WIB: Among 47 priced US real estate stocks, 46 rose and 1 fell today. Alexandria Real Estate Equities Inc (ARE) gained 4.86% to USD 44.34 with a typical hold time of 95 days and order activity favoring buys at 63%. AGNC Investment Corp (AGNC) rose 4.51% to USD 8.91 with a longer hold time of 105 days but more sell orders at 54%. CBRE Group Inc (CBRE) increased 4.24% to USD 141.27 with a notably short hold time of 11 days.
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
